Treatment Registry
TR-0015 Not verifiedRecorded August 2026Last verified September 2026

Brand semaglutide

Recorded for Gala Health · every brand semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

Historical price evidence from September 2026. Current availability and prices are not verified. These figures are not a current offer.

TermPer monthCharged today
Ozempic (brand semaglutide) - cash price

“From $1,299/month Cash price. Insurance may reduce cost.”

Per month$1,299Charged today$1,299
Price sources
Provider website · Gala Health

Current availability of this program is not verified.

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Term added: Ozempic (brand semaglutide) - cash price
  • August 2026 — Entry added to the register

Sourcing and terms

PharmacyNot disclosed as of August 2026
StatesAll 50 states
PrescriberBoth
Consult feeNot disclosed as of August 2026

Not yet checked: cancellation and membership.

Recorded from galaglp1.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. August 2026 — Prices read August 2026 by completing Gala's own intake with dummy data and stopping at the plan screen, before any payment details. The public marketing page shows only $179 a month.
  2. 2. August 2026 — The plan screen runs a countdown: "Only 24 discounts left" and "Yours is reserved for 9:57 min", above a "First shipment $120 OFF" banner. Those mechanics do not appear on any public page.

2 further notes concern other Gala Health programs and sit on the provider record.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0015
Medication category
brand semaglutide
Readings
2

Related records

Cite this entry

Treatment Registry. (2026). Gala Health — brand semaglutide (TR-0015). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0015

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.